{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:00:51Z","timestamp":1794200451694,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.drudis.2024.103938","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T12:22:20Z","timestamp":1709295740000},"page":"103938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Generation of a drug-induced renal injury list to facilitate the development of new approach methodologies for nephrotoxicity"],"prefix":"10.1016","volume":"29","author":[{"given":"Skylar","family":"Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-6148","authenticated-orcid":false,"given":"Weida","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2024.103938_b0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/FTD.0000000000000589","article-title":"Biomarkers of drug-induced kidney toxicity","volume":"41","author":"Griffin","year":"2019","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.drudis.2024.103938_b0010","doi-asserted-by":"crossref","DOI":"10.3949\/ccjm.69.4.289","article-title":"How to prevent, recognize, and treat drug-induced nephrotoxicity","volume":"69","author":"Guo","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.drudis.2024.103938_b0015","unstructured":"National Center for Health Statistics CfDCaP. Kidney Disease. https:\/\/www.cdc.gov\/nchs\/fastats\/kidney-disease.htm"},{"key":"10.1016\/j.drudis.2024.103938_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/japtr.JAPTR_336_18","article-title":"Nephrotoxicity: Role and significance of renal biomarkers in the early detection of acute renal injury","volume":"10","author":"Al-Naimi","year":"2019","journal-title":"J Adv Pharm Technol Res"},{"key":"10.1016\/j.drudis.2024.103938_b0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd6299","article-title":"Mechanism and reversal of drug-induced nephrotoxicity on a chip","volume":"13","author":"Cohen","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.drudis.2024.103938_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.793332","article-title":"In silico prediction and insights into the structural basis of drug induced nephrotoxicity. Original research","volume":"12","author":"Shi","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2024.103938_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-017-0536-3","article-title":"The 6R\u2019s of drug induced nephrotoxicity","volume":"18","author":"Awdishu","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.drudis.2024.103938_b0040","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2215\/CJN.07630717","article-title":"Drug-induced acute interstitial nephritis","volume":"12","author":"Moledina","year":"2017","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"key":"10.1016\/j.drudis.2024.103938_b0045","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.drudis.2024.103938_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104662","article-title":"An FDA\/CDER perspective on nonclinical testing strategies: classical toxicology approaches and new approach methodologies (NAMs)","volume":"114","author":"Avila","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.drudis.2024.103938_b0055","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/ndt\/gft071","article-title":"Animal models of chronic kidney disease: useful but not perfect","volume":"28","author":"Becker","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.drudis.2024.103938_b0060","series-title":"Clinical development success rates and contributing factors 2011\u20132020","author":"Thomas","year":"2021"},{"key":"10.1016\/j.drudis.2024.103938_b0065","article-title":"Biomarkers and in vitro strategies for nephrotoxicity and renal disease assessment","volume":"5","author":"Soares","year":"2020","journal-title":"J Nephrol Renal Dis"},{"key":"10.1016\/j.drudis.2024.103938_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.864441","article-title":"Application of the adverse outcome pathway concept to in vitro nephrotoxicity assessment: kidney injury due to receptor-mediated endocytosis and lysosomal overload as a case study. Original research","volume":"4","author":"Jarzina","year":"2022","journal-title":"Front Toxicol"},{"key":"10.1016\/j.drudis.2024.103938_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.863643","article-title":"Mapping adverse outcome pathways for kidney injury as a basis for the development of mechanism-based animal-sparing approaches to assessment of nephrotoxicity. Original research","volume":"4","author":"Mally","year":"2022","journal-title":"Front Toxicol"},{"key":"10.1016\/j.drudis.2024.103938_b0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2022.01.033","article-title":"Renal nano-drug delivery for acute kidney injury: current status and future perspectives","volume":"343","author":"Geo","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2024.103938_b0085","unstructured":"Administration USFaD. New Approach Methods (NAMs). https:\/\/www.fda.gov\/food\/toxicology-research\/new-approach-methods-nams"},{"key":"10.1016\/j.drudis.2024.103938_b0090","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tibtech.2015.11.001","article-title":"Kidney-on-a-chip technology for drug-induced nephrotoxicity screening","volume":"34","author":"Wilmer","year":"2016","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.drudis.2024.103938_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12938-020-0752-0","article-title":"Organ-on-a-chip: recent breakthroughs and future prospects","volume":"19","author":"Wu","year":"2020","journal-title":"BioMed Eng OnLine."},{"key":"10.1016\/j.drudis.2024.103938_b0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s43586-022-00118-6","article-title":"A guide to the organ-on-a-chip","volume":"2","author":"Leung","year":"2022","journal-title":"Nat Rev Meth Prime"},{"key":"10.1016\/j.drudis.2024.103938_b0105","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/jat.4331","article-title":"In silico prediction of potential drug-induced nephrotoxicity with machine learning methods","volume":"42","author":"Gong","year":"2022","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.drudis.2024.103938_b0110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11030-018-9882-8","article-title":"Development of an in silico prediction model for chemical-induced urinary tract toxicity by using na\u00efve Bayes classifier","volume":"23","author":"Zhang","year":"2019","journal-title":"Mol Divers"},{"key":"10.1016\/j.drudis.2024.103938_b0115","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/ci100176x","article-title":"Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research","volume":"50","author":"Fourches","year":"2010","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.drudis.2024.103938_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13321-018-0315-6","article-title":"A new semi-automated workflow for chemical data retrieval and quality checking for modeling applications","volume":"10","author":"Gadaleta","year":"2018","journal-title":"J Cheminf"},{"key":"10.1016\/j.drudis.2024.103938_b0125","unstructured":"World Health Organization (WHO) Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDDs). Oslo: WHO Collaborating Centre for Drug Statistics Methodology. 2000:20."},{"key":"10.1016\/j.drudis.2024.103938_b0130","unstructured":"World Health Organization (WHO) collaborating centre for drug statistics methodology. Guidelines for ATC classification and DDD assignment. Norwegian Institute of Public Health; 2021. 2022."},{"key":"10.1016\/j.drudis.2024.103938_b0135","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.drudis.2016.06.006","article-title":"FDA drug labeling: rich resources to facilitate precision medicine, drug safety, and regulatory science","volume":"21","author":"Fang","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.103938_b0140","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.26208","article-title":"High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury","volume":"58","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2024.103938_b0145","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/acs.chemrestox.7b00025","article-title":"Evaluation of DILI predictive hypotheses in early drug development","volume":"30","author":"Chan","year":"2017","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.drudis.2024.103938_b0150","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00204-019-02492-9","article-title":"Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations","volume":"93","author":"Albrecht","year":"2019","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.drudis.2024.103938_b0155","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hep.23317","article-title":"Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events","volume":"51","author":"Lammert","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2024.103938_b0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7150\/ntno.39804","article-title":"Effects of molecular weight and structural conformation of multivalent-based elastin-like polypeptides on tumor accumulation and tissue biodistribution","volume":"4","author":"Sarangthem","year":"2020","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.drudis.2024.103938_b0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","article-title":"BDDCS, the Rule of 5 and drugability","volume":"101","author":"Benet","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2024.103938_b0170","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","article-title":"The evolution of commercial drug delivery technologies","volume":"5","author":"Vargason","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.drudis.2024.103938_b0175","series-title":"StatPearls [Internet]","article-title":"Volume of distribution","author":"Mansoor","year":"2023"},{"key":"10.1016\/j.drudis.2024.103938_b0180","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1021\/ci800038f","article-title":"Mold2, molecular descriptors from 2D structures for chemoinformatics and toxicoinformatics","volume":"48","author":"Hong","year":"2008","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.drudis.2024.103938_b0185","series-title":"LogP\u2014making sense of the value","first-page":"1","author":"Bhal","year":"2007"},{"key":"10.1016\/j.drudis.2024.103938_b0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drugdisposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm Res"},{"key":"10.1016\/j.drudis.2024.103938_b0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1208\/s12248-022-00687-0","article-title":"State of the art and uses for the biopharmaceutics drug disposition classification system (BDDCS): new additions, revisions, and citation references","volume":"24","author":"Bocci","year":"2022","journal-title":"AAPS J"},{"key":"10.1016\/j.drudis.2024.103938_b0200","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s11095-015-1749-4","article-title":"Predicting clearance mechanism in drug discovery: extended clearance classification system (ECCS)","volume":"32","author":"Varma","year":"2015","journal-title":"Pharm Res"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:12:36Z","timestamp":1761225156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644624000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1359644624000631"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2024.103938","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of a drug-induced renal injury list to facilitate the development of new approach methodologies for nephrotoxicity","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2024.103938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103938"}}